Meningococcal meningitis - Prevention - 0 views
-
-
shaneep110 on 05 Sep 14The first paragraph and maybe the second/third are the only ones of value.
-
-
Meningococcal disease risk can be decreased by approximately 90% in household contacts of a patient by administration of antibiotics known to eradicate meningococcal carriage
-
hemoprophylaxis significantly decreased the risk of meningococcal disease for household contacts with a risk ratio of 0.11 for those receiving chemoprophylaxis
- ...17 more annotations...
-
This is based on a meta-analysis of 4 retrospective studies and one small trial with 1249 cases of meningococcal disease and more than 4200 household contacts
-
In the United States, antimicrobial chemoprophylaxis is the primary means for prevention of meningococcal disease among close contacts of a patient with invasive meningococcal disease
-
herefore, chemoprophylaxis should be recommended for the index patient with meningococcal disease and all household contacts within 24 hours of diagnosis of the primary case.
-
There are no high quality experimental trials addressing control policies for meningococcal disease and no adequate studies of chemoprophylaxis in day care settings. Nevertheless, current management guidelines support chemoprophylaxis within 24 hours for all close contacts
-
Chemoprophylaxis administered more than 14 days after contact with an index case is probably of no value. Also, chemoprophylaxis does not protect against subsequent reacquisition of N meningitidis.
-
Close Contacts Warranting Chemoprophylaxis for Meningococcal Disease
-
-- Kissing -- Sharing of toothbrushes -- Sharing of eating utensils -- Mouth-to-mouth resuscitation -- Unprotected contact during endotracheal intubation
-
Persons at Low Risk for Whom Chemoprophylaxis is Not Recommended
-
Casual contact (eg, at school or work) without direct exposure to patient’s oral secretions Indirect contact only (ie, only contact is with a high-risk contact and not a case) Health care worker without direct exposure to patient’s oral secretions
-
Rifampin, ceftriaxone, and ciprofloxacin
-
Rifampin - a reddish-brown antibiotic used chiefly to treat tuberculosis and leprosy. ceftriaxone - Treats infections caused by certain types of bacteria. This medicine is a cephalosporin antibiotic. cephalosporin - any of a group of semisynthetic broad-spectrum antibiotics resembling penicillin. ciprofloxacin - This medicine is a quinolone antibiotic that treats infections and is given to people who have been exposed to anthrax. quinolone - any of a class of antibiotics used in treating a variety of mainly Gram-negative infections, and thought to be responsible for antibiotic resistance in some microbes. Gram-negative - a staining technique for the preliminary identification of bacteria, in which a violet dye is applied, followed by a decolorizing agent and then a red dye. The cell walls of certain bacteria
-
-
azithromycin
-
azithromycin - Treats bacterial infections. This medicine is a macrolide antibiotic. macrolide - any of a class of antibiotics containing a lactone ring, of which the first and best known is erythromycin. lactone - an organic compound containing an ester group -OCO- as part of a ring. erythromycin - an antibiotic used in the treatment of infections caused byan antibiotic used in the treatment of infections caused by Gram-positive bacteria. It is similar in its effects to penicillin. Gram-positive - a staining technique for the preliminary identification of bacteria, in which a violet dye is applied, followed by a decolorizing agent and then a red dye. The cell walls of certain bacteria.
-
-
nasopharyngeal
-
the drug of choice is rifampin, which is both effective and inexpensive. For young children rifampin can be administered with greater patient acceptance in a flavored syrup. Rifampin is not recommended for use in pregnant women. Rifampin may interfere with the efficacy of oral contraceptives, and some antiepileptic and anticoagulant medications. Rifampin may also stain the urine orange for a couple days and may stain soft contact lenses. Ciprofloxacin is also not recommended for use in pregnant women.